The CUL4B gene mental retardation X-linked type 15 genetic test is a specialized diagnostic tool designed to identify mutations in the CUL4B gene, which are implicated in a form of X-linked mental retardation (XLMR). This condition, also known as Cabezas syndrome, is characterized by various intellectual disabilities, physical anomalies, and sometimes behavioral issues. The test is crucial for families with a history of XLMR, as it aids in the early diagnosis and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to detect abnormalities in the CUL4B gene. The process is meticulous and requires a sample of the patient's blood or saliva. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure accurate and reliable results.
The cost of the CUL4B gene mental retardation X-linked type 15 genetic test is 4400 AED. While the price may seem steep, it is a valuable investment in understanding and potentially mitigating the impact of this genetic condition. Early diagnosis can lead to better management of symptoms, tailored educational strategies, and improved overall quality of life for affected individuals.
The FGD1 Gene Mental Retardation X-Linked Type 16 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FGD1 gene, which are associated with X-linked mental retardation type 16 (MRX16). This condition is a rare genetic disorder that affects cognitive function and can lead to various degrees of intellectual disability. The test aims to provide crucial information for the accurate diagnosis and management of individuals suspected to have MRX16, enabling targeted interventions and support.
Carried out through advanced genetic sequencing techniques, the test analyzes the FGD1 gene for specific mutations that are known to cause the disorder. This is particularly important for families with a history of the condition, as it can help in understanding the risk for future generations.
The cost of the FGD1 Gene Mental Retardation X-Linked Type 16 Genetic Test at DNA Labs UAE is 4400 AED. The investment in this test can be invaluable for affected families, offering them insights into the genetic underpinnings of the condition and guiding them towards appropriate medical and psychological support services. It's a critical step in the journey towards personalized medicine, where treatments and interventions can be tailored to the individual based on their unique genetic makeup.
The "POGZ Gene Mental Retardation Autosomal Dominant Type 37 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the POGZ gene, which have been associated with autosomal dominant mental retardation type 37 (MRD37). This condition is characterized by various neurological and developmental challenges, including intellectual disability, delayed speech and motor milestones, and sometimes physical abnormalities. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect alterations in the POGZ gene that could lead to the development of MRD37, providing crucial information for the diagnosis, management, and understanding of the condition. By pinpointing specific genetic mutations, this test enables tailored care and support strategies for affected individuals and their families.
The EEF1A2 gene is associated with Mental Retardation, Autosomal Dominant Type 38 (MRD38), a condition characterized by developmental delays, intellectual disabilities, and sometimes physical abnormalities. The EEF1A2 gene plays a crucial role in protein synthesis within cells, and mutations in this gene can lead to the disruption of normal cognitive and physical development.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE, designed to detect mutations in the EEF1A2 gene. This test is crucial for individuals with a family history of MRD38 or those showing symptoms related to intellectual disabilities without a known cause. Early diagnosis through this genetic test can lead to better management of the condition, including tailored educational programs, therapy, and, in some cases, medication to manage symptoms.
The cost of the EEF1A2 gene test for Mental Retardation, Autosomal Dominant Type 38, at DNA Labs UAE is 4400 AED. This test is a valuable tool for families seeking answers to unexplained developmental delays or intellectual challenges, providing them with crucial information for managing the condition effectively.
The SYNGAP1 Gene Mental Retardation Autosomal Dominant Type 5 Genetic Test is a specialized diagnostic tool designed to identify mutations in the SYNGAP1 gene, which are known to cause a form of intellectual disability termed as Mental Retardation, Autosomal Dominant Type 5. This condition is characterized by a range of cognitive impairments, developmental delays, and in some cases, seizures or behavioral issues. The SYNGAP1 gene plays a crucial role in brain development and function, and mutations in this gene disrupt normal neurological processes, leading to the symptoms associated with the disorder.
This genetic test is conducted at DNA Labs UAE, a leading facility in the region for genetic and molecular diagnostics. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab to detect any mutations in the SYNGAP1 gene. The results from this test can provide essential information for families and healthcare providers, enabling them to understand the genetic basis of the condition, anticipate medical needs, and consider genetic counseling for family planning.
The cost of the SYNGAP1 Gene Mental Retardation Autosomal Dominant Type 5 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the valuable insights gained from this test can play a critical role in managing the condition, tailoring educational and developmental interventions, and improving the quality of life for affected individuals and their families.
The GRIN2B gene plays a crucial role in cognitive development and brain function. Mutations in this gene can lead to mental retardation autosomal dominant type 6, a condition characterized by intellectual disabilities and possibly other neurological issues. Genetic testing for mutations in the GRIN2B gene is vital for accurate diagnosis and management of the condition.
At DNA Labs UAE, individuals can undergo a genetic test specifically designed to identify mutations in the GRIN2B gene. The test is priced at 4400 AED and is conducted using state-of-the-art genetic sequencing technologies to ensure accurate and reliable results. This test is crucial for families seeking answers to developmental delays and intellectual challenges in their loved ones, providing them with essential information for appropriate care and interventions.
The "DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the DYRK1A gene, which have been linked to Autosomal Dominant Mental Retardation Type 7. This condition is characterized by intellectual disability and, in some cases, physical abnormalities and developmental delays. The test is crucial for individuals showing symptoms of the disorder or those with a family history, providing essential information for accurate diagnosis and management.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the DYRK1A gene. The results can offer insights into treatment options, management plans, and the risk of passing the condition on to future generations.
The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in the DYRK1A gene. Given the complexity of genetic disorders, the test is a valuable tool for individuals and families seeking answers about Autosomal Dominant Mental Retardation Type 7, providing them with crucial information to navigate the condition.
The KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the KIF1A gene, which are linked to a form of autosomal dominant mental retardation (Type 9). This condition is characterized by intellectual disabilities and, in some cases, neurological issues due to abnormalities in the KIF1A gene. The gene plays a crucial role in the transport of synaptic vesicles in neurons, and mutations can disrupt neural function and development.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to detect any alterations in the KIF1A gene that may be indicative of the condition. This genetic test is pivotal for families seeking answers to developmental delays and intellectual challenges in their loved ones, offering a pathway to targeted interventions and support.
At DNA Labs UAE, the cost of the KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is set at 4400 AED. This investment covers the comprehensive genetic analysis and the professional expertise required to interpret the results accurately. Given the complexity of genetic conditions, obtaining a precise diagnosis can be invaluable for affected individuals and their families, guiding them towards appropriate care and management strategies.
The PRSS12 gene mental retardation autosomal recessive type 1 genetic test is a specialized diagnostic examination aimed at identifying mutations in the PRSS12 gene, which are known to cause a form of intellectual disability transmitted through an autosomal recessive inheritance pattern. This condition is characterized by significantly below-average intellectual functioning and limitations in adaptive behavior, emerging during the developmental period. The PRSS12 gene plays a crucial role in neural development, and mutations in this gene can lead to a spectrum of cognitive impairments.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the PRSS12 gene to detect abnormalities that might be responsible for the condition. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, followed by advanced genetic sequencing to identify any mutations.
The cost of the PRSS12 gene mental retardation autosomal recessive type 1 genetic test is 4400 AED. This price includes the full process of sample collection, genetic analysis, and a detailed report of the findings. The results from this test can be crucial for families seeking a definitive diagnosis, understanding the genetic underpinnings of the condition, and exploring potential management or therapeutic strategies tailored to the genetic diagnosis. Additionally, it can provide valuable information for future family planning decisions.
The ST3GAL3 Gene Mental Retardation Autosomal Recessive Type 12 Genetic Test is a specialized diagnostic tool designed to detect mutations in the ST3GAL3 gene, which have been associated with a specific form of intellectual disability known as Mental Retardation, Autosomal Recessive Type 12. This condition is characterized by developmental delays, intellectual challenges, and in some cases, additional neurological symptoms. The test is crucial for families seeking to understand the genetic basis of intellectual disability in affected members, enabling them to make informed decisions regarding management and care.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the ST3GAL3 gene that may be responsible for the condition.
The cost of the ST3GAL3 Gene Mental Retardation Autosomal Recessive Type 12 Genetic Test is 4400 AED. While the price may seem steep, it reflects the sophisticated technology and expertise required to accurately identify mutations in the gene. For families affected by this condition, the test offers invaluable insights into the genetic underpinnings of the disorder, paving the way for personalized treatment plans and support strategies.
